Brought to you by www.DealSearchOnline.com May 29, 2012 Issue: Recent Health Care M&A Deals Spotlight on: Biotechnology Spotlight on: Medical Devices Conference Calendar Recent Health Care M&A Deals BIOTECHNOLOGY Acquirer Target Price Vidara...
In the largest Medical Device deal for April, Hologic (NASDAQ: HOLX), a company focused on diagnostic and medical imaging systems, is acquiring Gen-Probe (NASDAQ: GPRO) for $3.72 billion. Based in San Diego, GPRO develops, manufactures and markets molecular diagnostic...
In April’s largest Biotechnology deal, the British-Swedish pharmaceutical company AstraZeneca plc (NYSE: AZN) is acquiring Ardea Biosciences (NASDAQ: RDEA), a biotech that is focused on the discovery and development of small-molecule therapeutics treating gout and...
In March’s largest biotech deal, the Belgian firm ThromboGenics NV (Euronext: THR) is entering into an agreement with Novartis AG (NYSE: NVS) for the commercialization of ocriplasmin outside of the United States. This product candidate is indicated for the treatment...
Brought to you by www.DealSearchOnline.com May 21, 2012 Issue: Recent Health Care M&A Deals Spotlight on: Long-Term Care Spotlight on: Venture Capital Conference Calendar Recent Health Care M&A Deals BIOTECHNOLOGY Acquirer Target Price...
Alder BioPharmaceuticals, a Washington-based biopharma focused on antibody therapeutics, recently closed on a $38.0 million Series D financing. This comes four years after the company’s Series C round. The current round was led by new investor Novo Ventures and joined...